<DOC>
	<DOCNO>NCT00729716</DOCNO>
	<brief_summary>BioCart™II novel scaffold seed autologous chondrocytes use repair cartilage lesion knee . This study design compare efficacy safety BioCart™II treatment compare microfracture classical method treatment .</brief_summary>
	<brief_title>Comparison BioCart™II With Microfracture Treatment Cartilage Defects Femoral Condyle</brief_title>
	<detailed_description>Full thickness cartilage lesion typically incapable self repair , source pain morbidity lead early onset osteoarthritis . A classical method treatment microfracture hole drill subchondral bone allow influx bone marrow cell fill repair lesion . The result repair report mixed fibrocartilage recognize less efficient durable hyaline cartilage , physiological material making joint . In autologous chondrocyte implantation , sample cartilage remove non-weight bearing region joint cell grow expanded culture return knee repair damage cartilage . For implantation BioCart™II , chondrocytes grown presence proprietary growth factor maintain chondrocytes optimal condition subsequent repair . For implantation , cell seed completely human three dimensional spongelike scaffold hold cell correct topology allow rapid repair damage joint true physiological cartilage . BioCart™II user friendly surgeon patient alike give advantage method autologous chondrocyte implantation clinical use .</detailed_description>
	<criteria>Age 16 60 year Femoral condyle lesion ( medial , lateral trochlea ) Single contain lesion Symptomatic ( moderate severe pain VAS ) Caused trauma OCD Depth lesion 6 mm Size lesion 1.57.5 cm2 No general bone cartilage pathology No limb malalignment ( long leg stand Xray ) Mechanically stable knee Accompanying pathology menisectomy 50 % Willing able comply protocol undergo vigorous rehabilitation Signed informed consent Multiple cartilage lesion knee , location femoral condyle ( medial , lateral trochlear ) , deep 6 mm , small 1.5cm2 great 7.5cm2 , mild symptom , cause reason trauma OCD , unstable knee , accompany pathology 50 % menisectomy . Hyaluronic acid knee injection past 3 month , History chronic bone cartilage disorder , bilateral knee pain and/or cartilage lesion History neoplastic disease , chemotherapy treatment Chronic steroid intake , chronic pain medication use condition involve knee , use blood thinner ( past 10 day prior enrollment ) History allergy atopic disease , sensitivity blood product Evidence significant systemic disease , know coagulopathies acute injury might compromise patient 's welfare Pregnant lactate woman Substance alcohol abuse Microfracture affect knee within previous 2 year Participation concurrent trial Participation previous trial within 3 month Malignancy Taking specific drug osteoarthritis , chondroitin sulfate , diacerein , nglucosamine , piaseledine , capsaicin within 2 week baseline visit Chronic use anticoagulant Uncontrolled diabetes Active joint infection Other unstable cardiac pulmonary disorder Liver enzymes ( SGOT , SGPT , alkaline phosphatase ) two time upper limit normal result clinical investigator 's mind important clinically Clinical and/or radiographic disease index affected joint include : Osteoarthritis avascular necrosis Rheumatoid arthritis history septic reactive arthritis Gout history gout pseudogout affect knee Osteochondritis dissecans knee significant bone loss Bipolar articular cartilage involvement ( kiss lesion ) ipsilateral compartment ( i.e &gt; ICRS grade 2 oppose articular surface ) Associated damage underlie subchondral bone require osteochondral graft History secondary arthropathy ( i.e . sickle cell disease , Hemochromatosis , autoimmune disease ) Receiving prescription pain medication NSAIDs acetaminophen condition unrelated index knee condition BMI &gt; 40 kg/m2 Unable undergo MRI Any reason make patient poor candidate eye investigator</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Microfracture</keyword>
	<keyword>Cartilage repair</keyword>
	<keyword>Autologous chondrocyte implantation</keyword>
</DOC>